Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K.
- 29 October 2004
- journal article
- Published by Elsevier
- Vol. 33 (2) , 103-109
- https://doi.org/10.1016/s0163-4453(96)93005-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigensThe Lancet, 1994
- Effectiveness of Diethylcarbamazine in Treating Loiasis Acquired by Expatriate Visitors to Endemic Regions: Long-Term Follow-UpThe Journal of Infectious Diseases, 1994
- Tolerance and Efficacy of Single High-Dose Ivermectin for the Treatment of LoiasisThe American Journal of Tropical Medicine and Hygiene, 1993
- Onchocerciasis in members of an expedition to Cameroon: role of advice before travel and long term follow up.BMJ, 1992
- Loiasis in Endemic and Nonendemic Populations: Immunologically Mediated Differences in Clinical PresentationThe Journal of Infectious Diseases, 1991
- Loa loa and Mansonella perstans filariasis in the Chaillu mountains, Congo: parasitological prevalenceTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- Loa loa Infection in Temporary Residents of Endemic Regions: Recognition of a Hyperresponsive Syndrome with Characteristic Clinical ManifestationsThe Journal of Infectious Diseases, 1986
- Eosinophilia in Caucasians returning from the tropicsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- Usefulness of apheresis to extract microfilarias in management of loiasis.BMJ, 1983
- Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.BMJ, 1977